These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3525 related articles for article (PubMed ID: 22748834)
41. Untangling amyloid-β, tau, and metals in Alzheimer's disease. Savelieff MG; Lee S; Liu Y; Lim MH ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614 [TBL] [Abstract][Full Text] [Related]
42. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model. Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707 [TBL] [Abstract][Full Text] [Related]
43. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
44. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
45. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Terwel D; Dewachter I; Van Leuven F Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809 [TBL] [Abstract][Full Text] [Related]
46. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377 [TBL] [Abstract][Full Text] [Related]
47. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770 [TBL] [Abstract][Full Text] [Related]
48. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824 [TBL] [Abstract][Full Text] [Related]
49. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
50. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Götz J; Schild A; Hoerndli F; Pennanen L Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275 [TBL] [Abstract][Full Text] [Related]
51. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase. Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763 [TBL] [Abstract][Full Text] [Related]
52. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705 [TBL] [Abstract][Full Text] [Related]
53. Mouse models of Alzheimer's disease: the long and filamentous road. Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012 [TBL] [Abstract][Full Text] [Related]
54. [Neurobiology and molecular biology of Alzheimer's disease]. DeKosky ST Rev Neurol; 2002 Oct 16-31; 35(8):752-60. PubMed ID: 12402229 [TBL] [Abstract][Full Text] [Related]
55. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease. Lomoio S; López-González I; Aso E; Carmona M; Torrejón-Escribano B; Scherini E; Ferrer I J Alzheimers Dis; 2012; 31(2):285-300. PubMed ID: 22561329 [TBL] [Abstract][Full Text] [Related]
56. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
57. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]